iRaTe Series PLGF Immunoassay Analyzer Preeclampsia assessment

Clinical Application:

The iRaTe Series PLGF Immunofluorescence Quantitative Analyzer is a highly effective tool for early screening and risk assessment of pre-eclampsia in pregnant women. Its primary clinical application is in the early detection of pre-eclampsia, which is crucial for preventing severe complications during pregnancy. By measuring critical biomarkers like PLGF (Placental Growth Factor) and sFlt-1 (soluble fms-like tyrosine kinase 1), the analyzer enables healthcare providers to identify high-risk patients before symptoms become severe.

The device is particularly valuable in emergency rooms, at the bedside, in small laboratories, and in community hospitals where rapid diagnosis is essential. Its ability to deliver results within 12 minutes allows for quick decision-making and timely interventions, improving maternal and fetal outcomes.

Additionally, the iRaTe Series offers versatility beyond pre-eclampsia screening. It provides reagents for a wide range of diagnostic applications, including cardiovascular health (NT-proBNP), bone metabolism (AMH), anemia (FA), and renal function assessments. This multi-functionality makes it an indispensable tool in various clinical settings, ensuring comprehensive patient care.